Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
Hester H. van Boven(Leiden University), David A. Lane(Shenandoah University), Pieter H. Reitsma(Leiden University Medical Center), Vijoy Chowdhury(John Radcliffe Hospital), Jeanne‐Yvonne Borg(Leiden University), I. Scharrer(Goethe University Frankfurt), Trevor A. Bayston(Charing Cross Hospital), J. Conard(Hôtel-Dieu de Paris), Kenneth A. Bauer(VA Boston Healthcare System), Frits R. Rosendaal(Leiden University Medical Center)
Cited by 239
Related Papers
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k